• Skip to main content
  • Skip to primary sidebar

Alcohol Review

Alcohol understanding for all

  • Highlights
  • Events
    • AR2026
    • AR2025
    • Next year’s event
    • Earlier events
  • Register
  • About
    • Organisers
    • Contact
  • Log In

story

Interview: Quantifying alcohol’s liver risks

April 7, 2026

Watch preview. Please register for early access to full video.

Alcohol is well known to be among the biggest causes and contributors to liver disease, but there is still more to be found out. Alcohol Review spoke to Professor Zobair Younossi of Georgetown University, Washington DC about a recent Lancet paper in which he and his co-authors shed more light on the relationship. ■

Opinion: Be wary of GLP-1 messaging

April 1, 2026

By Phil Cain

A survey this week highlighted a 29% reduction in how often users of GLP-1 diet drugs consume alcohol and that they spent nearly a third less on alcohol in hospitality settings and a fifth less at home.

People working to reduce alcohol harm may feel like celebrating, but we should be wary of taking such findings at face value, not least because they are promoted by the alcohol industry consultancy KAM, in partnership with the UK alcohol industry’s Drinkaware charity.

Self-serving narratives and hype often appear to fill gaps in our knowledge. This has happened around alcohol-free beer and other nolo drinks. GLP-1s unproven effectiveness looks set to spawn a new wave of misleading narratives.

The alcohol industry’s promotion of GLP-1’s potential to reduce alcohol consumption should be taken with a shovel or two of salt. Industry public relations efforts typically focus on diverting attention from evidence-based policies. Increasing alcohol’s price and reducing its availability and marketing have been shown to reduce alcohol harm across the population. GLP-1s have no such evidence behind them.

Promoting GLP-1s’ potential to reduce alcohol consumption also provides the alcohol industry with a tale of woe it can use to plead for special treatment in government policy debates. This may help the industry win renewed tax breaks or a loosening of regulations. The evidence shows these wins for the industry would increase the harm its products cause.

It is worth asking a few questions when headlines appear about GLP-1s based on surveys or other weak evidence, especially when they come from alcohol industry sources. Below are a few ideas. [Please, feel free to suggest more in the comments section of the post on LinkedIn.]

  • A survey is no replacement for a full clinical trial. There has been no large-scale randomised control trial to confirm the anecdotal findings or to assess the side-effects when used for alcohol consumption.
  • One possible side-effect may result from the fact that not everyone who wants to drink less alcohol would benefit from eating less. In fact, a significant proportion of heavy drinkers are malnourished and may become more malnourished if they take GLP-1s to tackle their alcohol drinking.
  • It is also worth asking the degree to which the lower spending on alcohol is the result of the drug’s pharmaceutical action and how much the subtraction of £300 or so a month from a household’s disposable income to pay for GLP-1 medication. This might, in fact, simply be more evidence of the known effect of increasing alcohol’s price as a proportion of disposable income.
  • People taking GLP-1s are a self-selecting group of people making a conscious and costly decision to try to improve their health. It is possible such a group may reduce alcohol consumption even without taking GLP-1s, when compared to a sample of the general population.
  • These drugs show the potential to treat existing alcohol problems rather than avoiding problems before they start, so are inferior to “upstream” policies.
  • The enormous cost of GLP-1s falls on the consumer or, potentially, health insurers and taxpayers, rather than on the producers of the alcohol products that are the source of harm. Is this allocation of cost either efficient or fair? ■

Interview: How parents can set a better example (w/ Sergey Alexeev)

March 25, 2026

Please register for early access video

Parents should aim to shape household norms so that “alcohol is less central, less emotionally loaded and less available” to minimise harm to their children, according to Sergey Alexeev of the University of New South Wales. Alcohol Review caught up with him to find out more. To read the paper discussed here see https://onlinelibrary.wiley.com/doi/10.1002/hec.70084 ■

UK tracks AF beer for alcohol inflation

March 16, 2026

The UK’s official statistics office today said it added alcohol-free beer to the list of goods it uses to monitor inflation to “represent an uncovered area of the alcohol market”.

It unclear how a product containing no alcohol represents ones containing alcohol. Nobody knows the extent to which alcohol-free beer replaces alcoholic products. Its price is also not subject to alcohol tax or minimum pricing.

“There is currently no clear evidence for no-lo drinks taking the place of alcohol products to any significant degree,” a group of experts wrote in January.

AR Hype around the evidence-free idea that alcohol-free beer is reducing alcohol harm is arguably distacting attention from policies which are known to work. ■

How glam, wellness, empowerment and escapism associations sell alcohol to women

March 11, 2026

By Kristen Foley, Belinda Lunnay  and Paul Ward, including photos*

Ellidy pops into the bottle shop on her way out to dinner with friends.

She’s faced with rows of evocative labels – using artwork, imagery and symbols to help portray the essence and style of the alcohol on sale.

She narrows it down by wine variety, something local and in her price range. She chooses between two eye-catching labels: one with vivid pink flowers and another with a young woman’s face on the label, hidden by clouds.

She grabs one she thinks will mean something to the group of people she’s going to see.

Ellidy is a fictional shopper. But the labels she’s faced with are real examples from our research on how alcohol labels are designed to appeal to women.

This includes pink labels, and those featuring women’s body parts, high heels or needlework.

Here’s what else our research, published in the International Journal of Drug Policy, found.

We analysed 473 products – including wine, spirits and ready-to-drink products – and spotted five themes.

1. Pink, purple and glitter
Companies used pink, purple, petals and glitz, such as glitter, embossed glass, sparkles, and images of diamonds, in the product design and labe (pictured top).

This “pinkwashing” appeals to some women. But it perpetuates the stereotype of the pink, hyper-feminine consumer.

2. Names, bodies and body parts
Labels featured stereotypical and sexualised versions of women’s names, bodies and body parts. Examples included names such as “la femme” and “madame sass”, and images depicting breasts and an orgy (pictured).

Australia’s alcohol advertising code prohibits advertising that suggests social, sexual or other success.

3. Wellness
Our analysis found labels suggested alcohol was a form of wellness, balance and connection (pictured).

This included a wine called “Mother’s Milk”. This suggests alcohol may provide replenishment in a woman’s life and care for her as she cares for others.

Another was “One Lovely Day”, which featured young women holding hands in a forest.

4. Strong women
Alcohol promoted women’s strength, resilience and confidence. For instance, it showed them in positions traditionally associated with men, playing cricket, owning a vineyard, or exercising choice and power (pictured).

These depictions are typical of postfeminism, sometimes called “backlash” feminism, which focuses on individual women who succeed in the face of gendered adversity. This may be “doing it all” while keeping a happy, confident and “feminine” disposition.

Their success is then used to downplay the structural forces that disadvantage women. This includes sexism and misogyny, as well as gendered expectations around unpaid care and emotional labour.

Examples in this category included wines featured children with shiny purple and pink text saying “follow your dreams” or “chin up”.

5. Escaping reality
This group of products promoted the dissipation and disassociation alcohol can enable. This includes the wine label Ellidy looked at with clouds drifting over a woman’s face (pictured).

These kinds of marketing suggest alcohol can provide psychological distance from life’s pressures, somewhat like anaesthetic.

We found products that referenced mental health states such as “muddled up moscato” or “better days”. Others reflected desires for freedom, revelry or rest, such as “freebird”, “tail spin” or “silence”.

Reinforcing stereotypes
Marketing alcohol this way can reproduce harmful gendered stereotypes.

Such “femmewashing” can also be confusing for women. Alcohol may be marketed as sexy, empowering and offering escapism. Yet there’s a growing understanding of the health risks of drinking alcohol, including breast cancer.

And while it is laudable for companies to recognise women and celebrate their strengths and talents, not everyone’s a fan of this type of gendered marketing. Some feel powerless to stop it.

In other research, Australian women told us it communicates that women need to be hyper-feminine, sexy and happy if they want to succeed.

As part of Kristen’s PhD research, one woman said:

I think that there should be regulation of it […] it’s very cynical and destructive, I totally see that.

Another participant said women were conscious they were being targeted to prop up industry profits:

Large companies clearly prey on exhausted, time-poor women tempting them to find their ‘me time’ in a glass or several of wine.

Is this legal?
Our research with women shows they can often see through this marketing spin. However, it can also work in the background to reinforce harmful gendered norms, and associate drinking with femininity.

In Australia, there is no current regulatory mechanism to restrict gendered alcohol marketing, but this is needed for a number of reasons. For a start, it would bring Australia into line with World Health Organization advice to reduce gender stereotypes in alcohol control policies.

We also need to be cautious of repurposing feminism as a cheap gimmick to market empowerment as a commodity.

Some suggest commoditising feminism ironically worsens gender inequality by hiding its social and political drivers. It gives the impression that merely buying the right products will enable you to succeed as a woman. ■

*Note: All of Torrens University Australia. This article is republished from The Conversation under a Creative Commons license.

US alcohol deaths down but still elevated

March 2, 2026

US alcohol specific deaths fell by 4% last year compared to the year before while remaining 15% above pre-pandemic levels, according to early provisional full-year figures from the CDC. The total is likely to rise by a few percentage points over the coming months before a final figure is published early next year. The early provisional total for 2024 rose by around a thousand from the early provisional figure. ■

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 44
  • Go to Next Page »

Primary Sidebar

Follow us

  • Bluesky
  • Instagram
  • LinkedIn
  • Twitter
  • WhatsApp

Copyright © 2026 · Phil Cain Impressum

 

Loading Comments...